ArticleFrontiers in immunology2025
Mechanism of IFITM1 regulating epidural scar hyperplasia after laminectomy through SMAD3/CBR4 pathway.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Epidural scar hyperplasia is a prevalent complication post-laminectomy, contributing significantly to persistent low back pain and other symptoms, ultimately undermining surgical outcomes. Previous studies have identified fibroblast proliferation and differentiation, as well as adipocyte fibrosis, as central to this process, though the precise mechanisms remain elusive. Methods: A model of laminectomy was established using wild-type mice and IFITM1-KO mice. Methods such as HE staining and Masson staining were employed to assess the degree of fibrosis in the postoperative wound area of the mice. Immunofluorescence and Western blot were performed to verify the localization of IFITM1 and fibronectin. NIH-3T3 fibroblast cells and primary fibroblast cell models were established, and immunoblotting was used to detect changes in the expression levels of fibronectin, P-smad3, smad3, and IFITM1. Subsequently, co-immunoprecipitation was conducted to preliminarily demonstrate that CBR4 is a related protein of IFITM1. The amounts of adipose tissue and CBR4 in the postoperative wound area were compared between wild-type and IFITM1-KO mice in the laminectomy model. CBR4 localization was examined using immunofluorescence, followed by the establishment of an in vitro adipocyte model, where Oil Red O staining and other methods were utilized to confirm the process of adipocyte fibrosis and the roles of IFITM1/CBR4 therein. Results: In a murine laminectomy model, fibroblast proliferation, activation, and adipocyte fibrosis were found to exacerbate epidural scar formation. IFITM1, a critical protein regulating cell proliferation, is expressed in fibroblasts. The proliferation and activation of fibroblasts, characterized by high IFITM1 expression, were inhibited by suppression of the SMAD3 signaling pathway. Conclusion: These findings demonstrate that IFITM1 inhibits fibroblast proliferation and differentiation
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.